- Home
- ESLA vs AVX Comparison
ESLA vs AVX Comparison
Compare ESLA & AVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESLA | AVX |
|---|---|---|
| Founded | 2021 | 2017 |
| Country | United States | Canada |
| Employees | N/A | 3 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.9M | 63.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ESLA | AVX |
|---|---|---|
| Price | $1.06 | $0.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | 45.7K | ★ 281.3K |
| Earning Date | 03-18-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $530,767.50 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.76 | $0.51 |
| 52 Week High | $3.15 | $2.27 |
Technical Indicators
Market Signals| Indicator | ESLA | AVX |
|---|---|---|
| Relative Strength Index (RSI) | 41.56 | 31.86 |
| Support Level | $1.01 | N/A |
| Resistance Level | $1.35 | $0.84 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 14.04 | 4.19 |
Price Performance
Historical ComparisonAbout ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
About AVX Avax One Technology Ltd.
AVAX One Technology Ltd is a public company offering investors regulated access to the Avalanche (AVAX) ecosystem. By integrating the reliability of U.S. capital markets with the growth potential of decentralized finance, it seeks to create a bridge between traditional and digital finance. The company focuses on building a digital-asset treasury, fostering innovation, and investing in decentralized financial technologies that benefit from the Avalanche network.